These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10872091)

  • 1. Formulation of activated charcoal for per os administration to addicted subjects.
    Flament MP; M'bisi R; Leterme P; Gayot AT
    Drug Dev Ind Pharm; 2000 Jul; 26(7):731-6. PubMed ID: 10872091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and optimization of the activated charcoal suspension composition based on a mixture design approach.
    Ronowicz J; Kupcewicz B; Pałkowski Ł; Krysiński J
    Acta Pharm; 2015 Mar; 65(1):83-90. PubMed ID: 25781707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral administration of activated charcoal-sorbitol suspension as first aid in prevention of poison resorption?].
    Eyer P; Sprenger M
    Klin Wochenschr; 1991 Nov; 69(19):887-94. PubMed ID: 1812318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated charcoal in the treatment of drug overdose. An update.
    Palatnick W; Tenenbein M
    Drug Saf; 1992; 7(1):3-7. PubMed ID: 1536696
    [No Abstract]   [Full Text] [Related]  

  • 5. Removal of amitriptyline from simulated gastric and intestinal fluids using activated carbons.
    Valente Nabais JM; Ledesma B; Laginhas C
    J Pharm Sci; 2011 Dec; 100(12):5096-9. PubMed ID: 21918986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A ready-to-use activated charcoal mixture. Adsorption studies in vitro and in dogs: its influence on the intestinal secretion of theophylline in a rat model.
    Rademaker CM; van Dijk A; de Vries MH; Kadir F; Glerum JH
    Pharm Weekbl Sci; 1989 Apr; 11(2):56-60. PubMed ID: 2726418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2).
    Chiew AL; Isbister GK; Kirby KA; Page CB; Chan BSH; Buckley NA
    Clin Toxicol (Phila); 2017 Dec; 55(10):1055-1065. PubMed ID: 28644687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced activated charcoal delivery through small-bore tubing.
    Schneider SM; Michelson EA
    Vet Hum Toxicol; 1993 Dec; 35(6):503-5. PubMed ID: 8303817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Container residue after activated charcoal administration in the emergency department.
    Harchelroad F
    Vet Hum Toxicol; 1992 Feb; 34(1):13-4. PubMed ID: 1621355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man.
    Olkkola KT
    Br J Clin Pharmacol; 1985 Jun; 19(6):767-73. PubMed ID: 4027120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary aspiration of activated charcoal: a complication of its misuse in overdose management.
    Givens T; Holloway M; Wason S
    Pediatr Emerg Care; 1992 Jun; 8(3):137-40. PubMed ID: 1614903
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sucrose as a sweetener for activated charcoal.
    Cooney DO; Roach M
    Am J Hosp Pharm; 1979 Jun; 36(6):797-8. PubMed ID: 463898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Galenic formulation of an activated charcoal preparation. In vitro test of activity--1st clinical use].
    Rambourg-Schepens MO; Lecolier MD; Rambourg P; Gourdier B; Willemin JC; Buffet M
    J Toxicol Clin Exp; 1989; 9(4):261-3. PubMed ID: 2625674
    [No Abstract]   [Full Text] [Related]  

  • 15. Carbamazepine overdose--the effects of multiple dose activated charcoal.
    Wason S; Baker RC; Carolan P; Seigel R; Druckenbrod RW
    J Toxicol Clin Toxicol; 1992; 30(1):39-48. PubMed ID: 1542148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of drug absorption in simulated theophylline overdose.
    Minton NA; Glucksman E; Henry JA
    Hum Exp Toxicol; 1995 Feb; 14(2):170-4. PubMed ID: 7779441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration.
    Laine K; Kivistö KT; Laakso I; Neuvonen PJ
    Br J Clin Pharmacol; 1997 Jan; 43(1):29-33. PubMed ID: 9056049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activated charcoals: properties--experimental studies].
    Erb F; Gairin D; Leroux N
    J Toxicol Clin Exp; 1989; 9(4):235-48. PubMed ID: 2696789
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of type and amount of carboxymethylcellulose on in vitro salicylate adsorption by activated charcoal.
    Cooney DO
    J Toxicol Clin Toxicol; 1982 Jun; 19(4):367-76. PubMed ID: 7143523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dose of charcoal on the absorption of disopyramide, indomethacin and trimethoprim by man.
    Neuvonen PJ; Olkkola KT
    Eur J Clin Pharmacol; 1984; 26(6):761-7. PubMed ID: 6489417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.